James Peyer is CEO and Founder of Cambrian Biopharma, which is bridging the gap between academic discovery and drug development
Read More
AI biotech company Owkin has appointed Alban de La Sablière, formerly SVP Global Head of Partnering at Sanofi, as Chief Business Officer.
Read More
Owkin announced that two first-in-class rapid, affordable AI-based diagnostic solutions – designed to improve outcomes for patients with breast cancer and colorectal cancer – approved for use in Europe
Read More
An EU-funded project has shown its potential to transform the pharma industry, according to Owkin
Read More
Bristol-Myers Squibb is paying $80 million upfront to tap into Owkin's expertise
Read More
Exclusive partnership between Aether and Allonnia to accelerate the removal of harmful toxins from the environment to help improve global human health
Read More